NCT04143282View on ClinicalTrials.gov

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 20, 2019

Primary Completion Date

April 20, 2020

Study Completion Date

June 30, 2020

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Metformin plus chemotherapy

determine the effect of metformin along with standard chemotherapy

DRUG

Chemotherapy

standard chemotherapy

Trial Locations (1)

Unknown

Beni-Seuf University Hospital, Banī Suwayf

All Listed Sponsors
lead

Hager salah el din

OTHER

NCT04143282 - Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment | Biotech Hunter | Biotech Hunter